Kyntra Bio (KYNB)

• Market cap: $32.6M
• 1 day: -2.19%
• 5 days: 0.88%
• 1 month: 15.35%
• 3 months: 20.18%
• 6 months: 9.54%
• Year to date: -12.23%
• 1 year: -29.97%
• 5 years: -97.27%
• 10 years: -98.24%
• Sector: Healthcare
• Industry: Biotechnology

About: Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Employees: 34